Literature DB >> 7005522

Role of the kidney in hormone metabolism and its implications in clinical medicine.

D S Emmanouel, M D Lindheimer, A I Katz.   

Abstract

Uremia is accompanied by a variety of metabolic and endocrine disorders, due in part to impaired degradation of hormonally active peptides by the diseased kidney, and in part to the fact that the uremic environment interferes with the extrarenal degradation of certain hormones, or with their synthesis or secretion. It is not always possible to establish a direct cause and effect relationship between alterations in immunoassayable hormone levels and endocrine abnormalities because in uremia the circulating hormonal immunoreactivity frequently includes crossreacting components without biological activity and, in addition, hormonal effects on target organs are often altered. Alterations in the metabolism of pancreatic alpha and beta cell hormones and of prolactin in chronic renal failure and their effect on the metabolism of lipids and carbohydrates and on reproductive function in this condition are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7005522     DOI: 10.1007/bf01476870

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  27 in total

1.  Abnormalities in circulating beta cell peptides in chronic renal failure: comparison of C-peptide, proinsulin and insulin.

Authors:  J B Jaspan; M E Mako; H Kuzuya; P M Blix; D L Horwitz; A H Rubenstein
Journal:  J Clin Endocrinol Metab       Date:  1977-09       Impact factor: 5.958

2.  Selective deficiency of hepatic triglyceride lipase in uremic patients.

Authors:  R Mordasini; F Frey; W Flury; G Klose; H Greten
Journal:  N Engl J Med       Date:  1977-12-22       Impact factor: 91.245

Review 3.  Carbohydrate metabolism in uremia: a review.

Authors:  R A DeFronzo; R Andres; P Edgar; W G Walker
Journal:  Medicine (Baltimore)       Date:  1973-09       Impact factor: 1.889

4.  Abnormalities in the regulation of prolactin in patients with chronic renal failure.

Authors:  G Ramirez; W M O'Neill; H A Bloomer; W Jubiz
Journal:  J Clin Endocrinol Metab       Date:  1977-10       Impact factor: 5.958

5.  Uremia and insulin response.

Authors:  F B Westervelt
Journal:  Arch Intern Med       Date:  1970-11

6.  Endocrine abnormalities in patients undergoing long-term hemodialysis. The role of prolactin.

Authors:  F Gómez; R de la Cueva; J P Wauters; T Lemarchand-Béraud
Journal:  Am J Med       Date:  1980-04       Impact factor: 4.965

7.  Metabolic clearance and secretion rates of human prolactin in normal subjects and in patients with chronic renal failure.

Authors:  G D Sievertsen; V S Lim; C Nakawatase; L A Frohman
Journal:  J Clin Endocrinol Metab       Date:  1980-05       Impact factor: 5.958

8.  Abnormal carbohydrate metabolism in chronic renal failure. The potential role of accelerated glucose production, increased gluconeogenesis, and impaired glucose disposal.

Authors:  S Rubenfeld; A J Garber
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

9.  Pathogenesis and characterization of hyperglucagonemia in the uremic rat.

Authors:  D S Emmanouel; J B Jaspan; S F Kuku; A H Rubenstein; A I Katz; A H Huen
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

10.  Ovarian function in chronic renal failure: evidence suggesting hypothalamic anovulation.

Authors:  V S Lim; C Henriquez; G Sievertsen; L A Frohman
Journal:  Ann Intern Med       Date:  1980-07       Impact factor: 25.391

View more
  2 in total

Review 1.  Pharmacokinetics and pharmacodynamics of pegfilgrastim.

Authors:  Bing-Bing Yang; Anna Kido
Journal:  Clin Pharmacokinet       Date:  2011-05       Impact factor: 6.447

2.  Corticosteroid metabolism in isolated rat kidney in vitro. I. Formation of lipid soluble metabolites from corticosterone (B) in renal tissue from male rats.

Authors:  K Hierholzer; M Schöneshöfer; H Siebe; D Tsiakiras; P Weskamp
Journal:  Pflugers Arch       Date:  1984-04       Impact factor: 3.657

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.